 |
Research & Investigations
Researchers
E |
||||||||||||
A
| Joy E. Anderson, M.D. | Physical chemistry |
Clinical trials for multiple childhood cancers, specializing in leukemia & lymphoma |
B
Tumor immunology and virology |
|
Crystallography of proteins involved in cell cycle regulation |
|
Coorelation between pediatric hodgkin's disease and breast cancer |
|
| Michael Becker, M.D. | Stem cell research in hematology/oncology |
Clinical trials for multiple cancers |
|
Effects of radiation on DNA |
|
Development of novel immunotherapeutic approaches to the treatment of patients with lymphoproliferative disorders |
|
Blood transfusion immunology |
|
Signals that enable cancer cells to grow |
|
The papilloma virus and cervical cancer |
|
DNA sequences/how immune cells become cancerous |
|
Novel antigens that protect against cancer |
|
Genitourinary Tumors; Brachytherapy |
|
Pediatrics bone marrow transplant |
|
Clinical studies to treat basal cell carcinoma Microsopically controlled surgery for cutaneous malignancies |
C
Molecular mechanisms of prostate cancer progression |
|
Lung Tumors; Radiosensitization
|
|
Radiation oncology and use of MRI for detecting brain tumors for children |
D
Cancer vaccine development |
F
Tumor Oxygenation; Angiogenesis |
|
Overall direction of the Cancer Center and clinical trials for multiple cancers |
|
Viral etiology of malignancy |
|
Imaging methods to characterize tumor oxygenation and tumor environment |
|
T-cell differentiation |
|
Therapy for follicular lymphoma |
|
Abdominal imaging |
G
| Barry M. Goldstein, M.D., Ph.D. | Basic enzyme mechanisms. Rational design of anti-tumor and antiviral drugs |
H
|
Salivary function in long term survivors of cancer |
|
| DNA repair | |
Cancer Therapeutic Control; Radiation Oncology |
|
How hormones effect tumor growth Photodynamic therapy (PDT), for a variety of malignancies |
|
Molecular cell regulation |
|
Cell signaling |
|
| Treatment of chemotherapy-induced osteoporosis in breast cancer patients Mechanisms of cancer metastasizing to bone |
I
Clinical trials for Non-Hodgkin’s lymphoma, leukemia, and multiple myeloma |
J
| Craig Jordan, Ph.D. | A leader in leukemia and stem cell research |
K
Gastrointestinal Tumors; Brachytherapy |
|
| Peter C. Keng, Ph.D. | DNA repair and proteins regulating cell cycle |
| Scott D. Kennedy, Ph.D. | Magnetic resonance imaging |
| Manish Kohli, M.D. | Physician & researcher in urology oncology |
Tumor angiogenesis |
|
| Replicating Viruses for Cancer Therapy | |
The mechanisms that initiate blood cell development |
|
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer |
|
| Childhood Cancers |
L
Hematologic Disorders - Leukemia, Sickle Cell |
|
The molecular basis of oncogene co-operation, cell cycle control and signal integration mechanisms |
|
DNA-damage resulting in mutagenesis |
|
Cell signaling |
|
| Growth factor regulation of bone marrow cells. Clinical trials for leukemia and non-Hodgkin’s lymphoma |
|
Breast cancer |
|
Improve accuracy of radiation techniques / Image Segmentation; Brachytherapy |
|
Immune responses which can control tumor development |
M
Lung inflammation and lung cancer |
|
Cell Cycle and Cell Signaling Pathways |
|
Biochemistry / Biophysics RNA metabolism in human disease, studies focused on RNA decay pathway |
|
Biological and molecular mechanisms governing precursor cell division, differentiation and survival in the brain |
|
The metastatic process |
|
Self-help interventions for smoking cessation and behavioral change with various populations |
|
Early detection, prevention, and treatment of urologic malignancies |
|
Developing therapeutic strategies for treating cutaneous malignancies, specializing in cutaneous T-cell lymphomas |
|
Research Interests: Hematopoiesis and Stem Cell Biology |
|
Cancer biology Proteins in prostate cancer |
|
Dysregulation of tyrosine kinase receptors in type 2 diabetes and breast cancer |
|
Cancer control and clinical trials |
|
Immune regulation by T-cell subsets and their cytokines |
|
| Deborah Mulford, M.D. | Clinical research in leukemia |
| Karen Mustian, Ph.D. | Cancer Therapeutic Control; Exercise and Sport Psychology/Physiology |
N
Stem cell biology Eliminating cognitive impairment associated with the treatment of brain tumors |
O
Heart Motion Modeling; MRI Motion Tracking |
|
Orthopaedic oncology (bone and soft tissue tumors) |
|
Radiation oncology, specializing in urologic, gastrointestinal and neurologic cancers; supervisor of the Orange Service, which includes high dose brachytherapy, 3D treatment planning, and stereotactic radiosurgery; clinical protocols include an oligometastasis protocol for curative radiosurgical treatment of metastatic breast cancer; Translational Research Chair of the RTOG |
|
Behavioral medicine; health impact of lifestyle changes with particular focus on cigarette smoking, obesity, aging, child/adolescent outcomes measurement, and community intervention |
P
Pediatric hematology/oncology |
|
|
Breast, lung, gastrointestinal cancers and prevention |
|
Sonoelastography and detection of prostate cancer |
|
Surgical oncology |
|
The role of phospholipases and cycloxgenases in epidermal function |
|
Stem cell transplantation for leukemia, lymphoma and multiple myeloma |
|
Injury to the lung from exposure to chemotherapeutic agents Control of malignant lymphoma cells and regulation of antibody Producing lymphocytes by prostaglandins |
|
Oxidative stress in tissue injury and neoplasia |
|
| Colin Poulter, M.D. | Radiology |
Molecular and cellular biology of the skeletal system |
Q
R
Causes, treatment and prevention of bladder cancer |
|
Human Papillomavirus (HPV) and Human Immunodeficiency virus infections (HIV) |
|
Evolution of immune surveillance; thymocyte differentiation and thymic tumorigenesis |
|
| Joe Roscoe, M.D. | Design and analysis of research studies concerned with the therapeutic side effects of cancer treatment and patient quality of life |
Human papillomavirus vaccines |
|
Regulation of endochondral ossification |
|
3D Sonoelastography Imaging for Prostate Cancer |
|
Radiation oncology |
S
Urologic oncology |
|
Psychosocial adaptation to childhood cancer; complimentary medicine therapies |
|
Dr. Schell has been responsible for introducing stereotactic radiosurgery, CT/MRI image correlation and 3D treatment planning |
|
Protein expression in breast cancer |
|
Melanocyte biology and melanocyte tumors |
|
Immune-central nervous system interactions: autoimmunity and tumor immunotherapy |
|
Chronic leukemia; control of cell maturation |
|
Preventing tumors from developing resistance to chemotherapy |
|
| Abhay Ramchandra Shelke, M.D. | Quality of life issues in cancer patients receiving both chemotherapy and radiotherapy |
Antigen processing by IFN-induced proteasomes and T-cell immunity |
|
Modulation of pulmonary inflammatory using gene transfer techniques |
|
Breast and Lung Cancer |
|
Molecular mechanisms of signal transductions |
|
The process of tumor suppression |
T
| Muammar Tasbas, M.D. | Radiation oncology |
Dermatology |
U
V
W
Cancer cytogenetics; tumor suppression gene identification for human ovarian cancer |
|
Surgical oncology |
|
Diagnosis, treatment and prevention of diseases of salivary glands and salivary gland hypofunction |
|
| Jacqueline P. Williams, Ph.D. | Radiation Biology; Late Effects |
X
Y
How abnormal maturation of lymphocytes may lead to malignancies such as lymphoma. |
Z
Tumor progression and metastases |
|
How cellular proliferation is regulated |
|
Molecular oncology and cancer biology |